Percentage of women who 1) received or had documented use of most or moderately effective contraception and 2) received a long-acting reversible contraceptive method during the calendar year.
To focus the measure on the population of women interested in contraceptive services, the denominator excludes those individuals who did not receive or have documented use of a method if they indicated during the year that they did not want these services, as well as those who are eligible for postpartum contraceptive services during the measurement period.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Primary measure: Eligible women who received or were documented to be using a most (i.e., sterilization, implants, intrauterine devices or systems (IUD/IUS) or moderately effective (i.e., injectables, oral pills, patch, or ring) contraceptive method.
Sub-measure: Eligible women provided a long-acting reversible contraceptive method (IUD or implant).
-
1.15 Denominator
All women, aged 15-44, with a qualifying encounter in the calendar year
-
Exclusions
- Documentation of anatomical infecundity due to removal of uterus and/or bilateral ovaries, and
- Among those who did not receive or be documented to use a most or moderately effective method in the measurement period, those who indicated they did not want contraceptive services, and
- Those who had prenatal visit between 1/1/XX-1 (year prior to the measurement year) and 9/30/XX (the measurement year) with a live birth date, if documented, or a documented estimated delivery date between 10/1/XX-1 and 9/30/XX, provided they did not have a documented ectopic pregnancy intrauterine fetal demise, early pregnancy loss, or abortion. The inclusion in this measure of those who were documented to have a non-live birth ensures that whether or not the contraceptive needs of these individuals are met is measured, as the peripartum measure excludes these individuals in order to focus on the peripartum care pathway.
-
Most Recent Endorsement ActivityEndorsed Perinatal and Women's Health Spring 2022Initial EndorsementLast Updated
-
StewardUniversity of California, San FranciscoSteward Organization POC EmailSteward Organization Copyright
N/A
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-